Regeneron Pharmaceuticals, Inc.
REGN
Revenue
3.68B
▲646.90M▲21.36%
3 Months ChangeAssets
38.22B
▲674.00M▲1.80%
3 Months ChangeLiabilities
8.28B
▲122.70M▲1.50%
3 Months ChangeFree Cash Flow
815.80M
▼-562.80M▼-40.82%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 10-Q
ID: 0001804220-24-000040
2024-10-31
Form 8-K
ID: 0001804220-24-000038
2024-10-07
Form 8-K
ID: 0001104659-24-106432
2024-08-01
Form 10-Q
ID: 0001804220-24-000028
2024-08-01
Form 8-K
ID: 0001804220-24-000026
2024-07-08
Form 8-K
ID: 0001104659-24-078172
2024-06-20
Form 8-K
ID: 0001104659-24-073372
2024-05-02
Form 10-Q
ID: 0001804220-24-000017
2024-05-02
Form 8-K
ID: 0001804220-24-000015
2024-02-02
Form 8-K
ID: 0001804220-24-000006